Objective: Polymorphisms in several genes of the renin-angiotensin system have been implicated as risk factors for myocardial infarction and ischaemic heart disease. In particular, it has been suggested that the angiotensin converting enzyme insertion / deletion 1166 (I / D) polymorphism and the angiotensin II type 1 receptor A C polymorphisms might act synergistically to increase the risk of myocardial infarction. The aim of this study was to investigate associations between the angiotensin converting enzyme I / D polymorphism and angiotensin II type 1 receptor polymorphisms and ischaemic heart disease. Methods: We screened 331 white European patients who were recruited for routine angiographic investigation of chest pain, and 287 healthy white European controls for the 1166 angiotensin converting enzyme I / D and angiotensin II type 1 receptor A C polymorphisms, and related the genotype frequencies to angiotensin converting enzyme levels and the clinical phenotypes of atheroma and history of myocardial infarction. Results: Angiotensin converting enzyme levels were related to I / D polymorphism but not to angiotensin II type 1 receptor polymorphism genotypes. I / D polymorphism and angiotensin II type 1 receptor genotypes did not relate individually to risk of myocardial infarction or atheroma in univariate or multivariate analysis. However, evidence of a synergistic relationship between the AC / II and CC / DD genotypes and coronary stenosis in the major arteries was found. No evidence of any relationship between these polymorphisms and history of myocardial infarction by World Health organisation (WHO) criteria was detected. Conclusion: These findings suggest that there is a weak 1166 relationship between the angiotensin converting enzyme I / D and angiotensin II type 1 receptor A C polymorphisms and coronary atheroma, but no evidence of a relationship with history of myocardial infarction.
Introduction
mediates regulation of regional blood flow, hyperplastic and hypertrophic vascular smooth muscle cell proliferation The renin-angiotensin system is one of the major and migration [4] , activation of monocytes [5] , synthesis of regulators of blood pressure, and fluid and electrolyte PAI-1 [3, 6] , increased collagen matrix production by homeostasis. Angiotensin converting enzyme (ACE) is a fibroblasts [7] , and regulation of local sympathetic activity, zinc metalloprotease that generates angiotensin II, a pressor and tachycardic responses [8] . It may also be powerful vasopressor octapeptide, by cleaving the carboxinvolved in platelet activation and aggregation [5] and the y-terminal dipeptide from angiotensin I [1, 2] . It also maintenance of cardiovascular structure and repair [9, 10] inactivates bradykinin, a vasoactive nonapeptide that inhib-(for review, see [11] ). The prominent role of the reninits smooth muscle cell proliferation and is a stimulus for angiotensin system in cardiovascular regulation suggests t-PA secretion, by breaking it down to form kinin degrathat component gene abnormalities could modulate cardation products [3] . It is the binding of angiotensin II to its diovascular disease processes, and polymorphisms in sevreceptor, the angiotensin II type 1 receptor (AT R) that eral genes within the renin-angiotensin system have been 1 linked with cardiovascular disorders [12] .
A 287 base-pair insertion / deletion (I / D) polymorphism 2. Methods in intron 16 of the ACE gene has been identified, which accounts for between 26 and 47% of variation in plasma White European patients (331) were recruited from ACE levels [13] [14] [15] . Subjects that are homozygous for the Leeds General Infirmary as reported previously [26] and insertion allele have the lowest plasma ACE levels, Pinderfields Hospital in Wakefield, where routine angiogheterozygotes have intermediate and homozygotes for the raphy for investigation of chest pain or suspected CAD deletion allele have the highest ACE levels [14] . Numerwas performed. Healthy white European control subjects ous studies have suggested an association between the D (287) were recruited from local Family Health Services allele and myocardial infarction (MI) [16] [17] [18] [19] [20] [21] , including Authority general practice registers. Each subject gave two recent meta-analyses [22, 23] , although several studies informed consent according to a protocol approved by the have failed to show any association [24, 25] , including a United Leeds Teaching Hospitals NHS Trust and the recent study by our group [26] . The evidence for an Pinderfields Health Trust Ethics Committees. The invesassociation between the DD genotype of ACE and cortigation conforms with the principles outlined in the onary artery disease (CAD) is less strong, with several Declaration of Helsinki. The presence of CAD was defined negative studies [27, 28] , including our own [26] . However, as stenosis of at least 50% in a major coronary artery, or significant associations were found in other studies [19, 20] , one of their branches, as determined by angiography. The including the Caerphilly Heart Study [29] and, in parextent of disease was classified as the number of arteries ticular, with coronary heart disease (CHD) in subjects with with stenosis $50% as zero, one, two or three-vessel NIDDM [30] . As the I / D polymorphism lies within an disease. Diagnosis of MI was ascertained from patients' intron, it is unlikely to be the functional variant itself, but hospital records using the WHO criteria [37] of two out of rather in linkage disequilibrium with a functional variant three of the following: ST elevation of 1 mm in two or either within the ACE gene or in a neighbouring region of more successive leads, typical chest pain lasting for longer the chromosome [18, 26, 31, 32] . than 20 min duration, and a creatine kinase rise of more The human AT R is present predominantly in vascular than twice the baseline value.
1 1166 smooth muscle cells. An A C substitution in the 39 Free-flowing blood samples were taken after an overuntranslated region of the AT R has been identified, which night fast of at least 10 h and abstention from smoking 1 does not alter a potential mRNA polyadenylation or between 8 and 9.30 a.m. A 10-ml volume of whole blood destabilisation signal and is therefore unlikely to be was collected into EDTA, for DNA extraction, and lithium functional [33] . However, it may be in linkage disequilibheparin, for plasma lipid analysis. Hypertension was rium with a functional variant that could affect stability of defined as being present in controls if the mean blood the mRNA or the regulation of expression of the gene pressure was greater than 160 mmHg systolic or 90 mmHg [7, 34] . Thus, both the I / D polymorphism and the AT R diastolic, and in patients if the subject was described 1 polymorphisms are believed to be markers for functional previously as being hypertensive and was receiving treatpolymorphisms that have yet to be defined. ment. The body mass index (BMI) was calculated from Several groups have studied the relationship between the weight in kilograms divided by the square of height in
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AT R A C polymorphism and disease. The AT R metres. A note was taken of current drug therapy, and 1 1 polymorphism has been found to relate to aortic stiffness smoking history was recorded. Smokers were defined as in Caucasian hypertensive subjects [7] . In two studies, the subjects who currently smoked or who had ceased to ECTIM study [25] and a study of Japanese CAD subjects smoke within the last ten years. All other subjects were by Nakauchi et al. [35] , associations between the ACE I / D classified as non-smokers. polymorphism and AT R polymorphisms and MI, and
Measurements of cholesterol and triglycerides were 1 between the AT R polymorphism and CAD, respectively, made using a Hitachi 747 auto-analyser (Boehringer 1 have been found. However, a recent study of Caucasian Mannheim, Mannheim, Germany). Genomic DNA was subjects by Jeunemaitre et al. [36] failed to confirm these extracted using a detergent and salt-exchange method [38] . results.
Plasma ACE activity for each sample was determined We previously screened 258 white European patients using standard methodologies based on the hydrolysis of who were recruited with suspected CAD for several ACE furanacrylol-1-phenylalanyl-glycylglycine (FAPGG) by polymorphisms including the I / D polymorphism, and ACE with the subsequent decrease in absorbance at 340 found no relationship with MI or atheroma [26] . We have nm being a measurement of ACE activity. The coefficient now extended this study group to include an additional 73 of variation at 80 IU / l was 6% and at 250 IU / l, it was patients, and a set of 287 healthy white European controls.
3.5-4%. The aim of this study was therefore to investigate associaThe I / D polymorphism was genotyped as previously tions between the ACE I / D polymorphism and AT R described (Rigat et al. 1992 ) [26, 39] and the possibility of 1 polymorphisms and ischaemic heart disease (IHD) in 331 mistyping I / D heterozygotes as DD homozygotes due to white European patients and 287 healthy controls.
preferential amplification of the smaller D allele was addressed by a further amplification using the original characteristics of patients and controls with AA, AC or CC antisense primer together with a primer that was specific genotype were compared by one-way ANOVA. Chifor the insertion in DD samples, as previously described squared tests were used to compare AT R genotype in 1 [40] . Subjects with one 490 bp band on an agarose gel patients with and without atheroma. Sex, smoking and were classified as II (insertion), subjects with both 490 and hypertension were compared between patients and con-190 bp bands were classified as ID, and subjects with only trols, and between AT R genotype groups, by chi-squared 1 a 190 bp band were classified as DD (deletion). One tests. Age was compared between groups by Kruskalpatient and 14 controls were identified who had been Wallis tests. Hardy-Weinberg's equilibrium was tested by mistyped as DD homozygotes. The I / D genotype could the chi-squared test. not be determined for one patient and eight controls due to Linear regression models, including age, sex, BMI, the poor quality of DNA samples.
smoking, cholesterol, triglycerides, hypertension, I / D Amplification of DNA for genotyping the angiotensin II polymorphism genotype and AT R genotype were used to 1 type 1 receptor (AT R) polymorphism was carried out by determine which of these factors would have a significant 1 polymerase chain reaction (PCR) in a final volume of 25 influence on ACE levels. A general factorial ANOVA ml containing 100 ng of genomic DNA, 20 pmol of each model was used to determine whether, after adjusting for primer, 20 mmol / l Tris-HCl (pH 8.4), 50 mmol / l KCl, the covariates thus identified, the relationship between 0.2 mmol / l of each dNTP, 2 mmol / l MgCl and 1.5 U of ACE levels of patients and controls would be altered. 2 Taq polymerase (GIBCO, BRL, Gaithersburg, MD, USA). Age, sex, BMI, smoking, cholesterol, triglycerides, Samples were overlaid with oil. Primers for amplification hypertension, ACE levels, I / D polymorphism genotype of a 166 bp sequence, as described by Hingorani and and AT R genotype were entered into logistic regression 1 Brown [41] were: models to determine which variables would remain as significant predictors of atheroma and MI. An interaction 59ATAATGTAAGCTCATCCACCAAGAAG39 and term was created between the I / D polymorphism and AT R genotypes and this was also entered into the model. controls are shown in Table 1 . Due to incomplete medical DNA fragments were separated on 3% NuSieve agarose, histories, 69 control subjects had no data on smoking habit and photographed over a UV transilluminator after staining or hypertension. Samples were not available for determiwith ethidium bromide. Two independent assessors', who nation of ACE levels for 47 patients and 12 controls. The were blind to the clinical characteristics of the patients, control group was significantly younger than the patients, analysed the results. Afl II digestion yielded two bands of and had lower BMI, cholesterol levels and triglyceride 139 and 27 bp in the presence of the restriction site (C levels than the patients. The patients were predominantly allele), and only one band of 166 bp in the absence of the male (69.2%), whereas the controls were predominantly restriction site (A allele). Heterozygotes (AC) showed all female (54.0%). The patient group had a higher prevalence three bands.
of hypertension and smoking compared with the controls. There was no difference in ACE levels between the patients and controls.
Statistics
All genotypes were in Hardy-Weinberg equilibrium. There were no differences in any of the clinical characAge was treated as a non-parametric variable. Values for teristics of the patient group when sub-divided by AT R triglyceride, cholesterol and BMI exhibited a log-normal 1 genotype (data not shown). ACE levels were not associated distribution and these values were log-transformed to with AT R genotype (Table 2) , and did not differ between permit the use of parametric methods. Patients and controls 1 AA, AC or CC patients and controls. As reported previouson ACE inhibitor therapy (n559 and n510, respectively) ly [26] , ACE levels were very strongly associated with I / D were excluded from analyses of ACE genotype / level polymorphism genotype in both patients and controls interactions.
( and controls). II homozygote patients had significantly higher ACE levels than II homozygote controls ( p5 One-hundred and twenty two of the patients had a 0.004), but ACE levels did not differ between ID and DD positive history of MI, 235 of the patients had stenosis patients and controls.
.50% in one, two or three vessels, as defined by coronary In linear regression analysis to determine the factors that angiography, and ten patients with no atheroma and 112 influence ACE levels (removing patients and controls on patients with atheroma had a positive history of MI ( p, ACE inhibitors prior to analysis), in patients, the I / D 0.0005). No differences were found between the AT R 1 polymorphism genotype accounted for 10.5% of variation genotypes or ACE I / D genotypes of the patients and in levels ( p,0.00005) and triglycerides accounted for a controls (Table 3) , or the allele frequencies of either further 2.7% ( p50.01), leaving 86.8% of variation in polymorphism. There was no association between ACE ACE levels unaccounted for. In controls, the I / D polylevels and history of MI, or within the subgroup of patients morphism accounted for 22.5% of variation in ACE levels with angiographic evidence of atheroma, compared with ( p,0.00005), age for a further 7.6% ( p50.0002) and sex controls. Neither the AT R genotype nor the I / D poly-1 for a further 3.1% ( p50.01), leaving 66.8% of variation in morphism genotype was found to be related to history of ACE levels unaccounted for. Using a general factorial MI, or within the subgroup of patients with atheroma, ANOVA model and adjusting for I / D polymorphism confirming our previous findings [26] . In addition, no genotype, age, sex and triglyceride levels, only I / D differences were found when comparing patients with a polymorphism genotype ( p,0.0005), age ( p50.02) and positive history of MI to patients with no history of MI and triglycerides ( p50.001) remained as significant indepencontrols for AT R genotype when subjects were already 1 dent predictors of ACE levels, and the adjusted mean ACE subdivided by their I / D polymorphism genotype (data not levels did not differ between patients and controls (adshown). justed means: patients, 77.6; controls, 77.7 IU / l).
In logistic regression analysis, I / D polymorphism geno- group. There was no association between ACE levels, angiogIn order to test the strength of these results, a chiraphic evidence of atheroma, or the number of diseased squared test was used to look for heterogeneity in gene vessels, compared with controls and no association was frequencies of patients with atheroma compared with found between AT R genotype or I / D polymorphism patients with no angiographic evidence of atheroma and 1 genotype and the presence of atheroma, or with the number controls. When the patients with atheroma, no atheroma of diseased vessels (data not shown), confirming our and controls were sub-divided by AT R polymorphism 1 previous findings [26] . genotype (Table 5) , there were no significant differences in When I / D polymorphism genotyped patients and conthe I / D polymorphism genotype distributions. trols were sub-divided by their AT R genotype (Table 4) ,
In logistic regression models, I / D polymorphism geno-1 within the ACE II genotype group, no differences were type, AT R genotype, an interaction term between the two, 1 found between genotype distributions of patients with and ACE levels were not significant independent predictors atheroma and controls. However, when patients with no of the presence of atheroma, as detected by coronary atheroma were compared with patients with atheroma, a angiography. However, as expected, age, smoking, hylarge number of AC heterozygotes were found in the group pertension, triglycerides and male sex were significant with no atheroma ( p50.009). Comparing the group independent predictors of atheroma. Odds ratios (95% CI): without atheroma with the controls, again there was an age 1.08 (1.06-1.11) ( p,0.00005), smoking 1.61 (1.21- genotype group, which was found in 18% of cases, but also in 13% of controls. In a study of Japanese CHD patients [35] , the ACE DD genotype was found to be related to MI, and the C allele of the AT R gene was 
Discussion
found to be associated with increased severity of CAD. However, no relationship was found between the freThe prominent role of the renin-angiotensin system in quencies of the ACE and AT R genotypes. In 1997, 463
1 cardiovascular regulation suggests that component gene Caucasian patients undergoing coronary angiography were abnormalities could modulate cardiovascular disease prostudied in the CORGENE study [36] . Of these, 156 had a cesses [12] . The ACE I / D polymorphism is thought to be history of MI. No association was found between the ACE in linkage disequilibrium with a functional variant that 1 When patients and controls were sub-divided by both 4.1. ACE levels, polymorphism genotypes and I / D polymorphism and AT R genotype, as was performed 1 cardiovascular risk in the ECTIM study [25] , within the ACE DD group, the AT R CC genotype was found to be associated with the 1 In this study, there were no differences in ACE levels presence of atheroma, compared with the group with no after adjusting for I / D polymorphism genotype, age, sex atheroma ( p50.047) and when compared with the control and triglyceride levels between the patient and control group ( p50.05). There was no significant difference groups, or ACE levels between AT R genotypes of between the genotype distributions of the group with no 1 patients and controls. As reported previously atheroma and the control group. This suggests that it was [14, 15, 31, 32, 42] , ACE levels were very strongly associthe atheroma group that had an unusual genotype disated with I / D polymorphism genotype in both patients and tribution, with an excess of AC / DD and CC / DD genotype controls and, in addition, II homozygote patients were groups. This provides evidence that there is a positive found to have significantly higher ACE levels than II association between the AC / DD and CC / DD genotypes homozygote controls. No association was found between and evidence of large vessel disease. ACE levels and hypertension, MI, angiographic evidence Within the ACE II group, no differences were found of atheroma or the number of diseased vessels. These between genotype distributions of patients with atheroma results support previous findings that ACE levels were not and controls. However, unexpectedly large numbers of AC related to hypertension [43, 44] or MI [20] , but are at heterozygotes were found in the no atheroma group, when variance with two other studies [18, 42] compared with the atheroma group and the controls. This suggests that it was the gene frequencies of the no possible synergy between the ACE I / D polymorphism and AT R genotypes, and the current study, suffer from the atheroma group that were unusual. The patient group 1 problem of the small numbers of patients involved in consisted of subjects undergoing coronary angiography for subgroup analyses. However, this problem could only be routine investigation of chest pain. Patients with no resolved by performing meta-analysis of the published angiographic evidence of atheroma thus had chest pain for data, or by performing a large prospective study. another reason, for example, stenosis of smaller vessels. It A major strength of the present study is the inclusion of is thus possible that patients with small vessel disease as a control group of healthy white European subjects from opposed to large vessel disease might have an excess of the same locality as the patient group. Despite the fact that the AC / II genotype, which might be protective against the controls were not age-or sex-matched for the patient development of large vessel disease. group, the genotype frequencies for patients and controls In order to test the validity of these findings, a chiwere very similar. This strengthens the results of the squared test was used to look for heterogeneity in gene present study, those by Jeunemaitre et al. [36] and our frequencies of patients with atheroma compared with previous study [26] , which failed to show any association patients with no atheroma and controls (as exemplified by of the ACE I / D polymorphism with MI. Chowdhury et al. [45] ). If synergy between the CC and
In conclusion, the present study demonstrated a weak DD genotypes, and between the AC and II genotypes, is association between the ACE I / D polymorphism, AT R 1 valid, significant heterogeneity is expected in cases, but not 1166 A C polymorphism and angiographic evidence of IHD. in controls. In fact, no heterogeneity of genotypes was seen Further analysis of the data failed to confirm these in any of the three groups in this study. This suggests that findings, which suggests that they are chance observations these results could be a chance finding, especially because in a study group that has undergone multiple measurethe p values for the CC / DD interaction were only just ments. Evidence for a role for the genetics of the reninsignificant. However, a p value of 0.009 for the AC / II angiotensin system in CAD remains unconvincing and, in interaction suggests that this finding is more likely to be either case, it is doubtful that screening for the DD/ CC valid.
genotype in the general population would have any clinical relevance because of their limited discriminatory value.
Conclusion

